Wikidata

(Q28256478)

English

Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomas

scientific article

In more languages

Statements

title
Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomas (English)
0 references
author
E Claire Dees
series ordinal
3
object named as
E Claire Dees
0 references
author name string
Howard A Burris
series ordinal
1
0 references
Herbert I Hurwitz
series ordinal
2
0 references
Afshin Dowlati
series ordinal
4
0 references
Kimberly L Blackwell
series ordinal
5
0 references
Bert O'Neil
series ordinal
6
0 references
Paul K Marcom
series ordinal
7
0 references
Matthew J Ellis
series ordinal
8
0 references
Beth Overmoyer
series ordinal
9
0 references
Suzanne F Jones
series ordinal
10
0 references
Jennifer L Harris
series ordinal
11
0 references
Deborah A Smith
series ordinal
12
0 references
Kevin M Koch
series ordinal
13
0 references
Andrew Stead
series ordinal
14
0 references
Steve Mangum
series ordinal
15
0 references
Neil L Spector
series ordinal
16
0 references
publication date
10 August 2005
0 references
volume
23
0 references
page(s)
5305-13
0 references
issue
23
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q28256478&oldid=1601187330"